Pfizer-Seagen deal faces June 12 deadline for US antitrust review (correct*)
Pfizer and Seagen have filed antitrust paperwork for their $43 billion deal with US regulators and face a June 12 deadline. The regulatory clock hasn’t yet started for the reviews in...To view the full article, register now.
Already a subscriber? Click here to view full article